4.8 Article

Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors

期刊

JOURNAL OF CLINICAL INVESTIGATION
卷 123, 期 10, 页码 4375-4389

出版社

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI67465

关键词

-

资金

  1. Samsung Biomedical Research Institute [SBRI B-B00-08-3]
  2. V Foundation for Cancer Research
  3. American Cancer Society Research Scholar Grant
  4. NIH [P01CA66726, R01CA118375, P01CA45548]
  5. NCI/NIH [CA100193]
  6. Garrett B. Smith Foundation
  7. Ted Driven Foundation
  8. Cancer Research UK [12077] Funding Source: researchfish

向作者/读者索取更多资源

Progression of premalignant lesions is restrained by oncogene-induced senescence. Oncogenic Ras triggers senescence in many organs, including the lung, which exhibits high levels of the angiogenesis inhibitor thrombospondin-1 (TSP-1). The contribution of TSP-1 upregulation to the modulation of tumorigenesis in the lung is unclear. Using a mouse model of lung cancer, we have shown that TSP-1 plays a critical and cell-autonomous role in suppressing Kras-induced lung tumorigenesis independent of its antiangiogenic function. Overall survival was decreased in a Kras-driven mouse model of lung cancer on a Tsp-1(-/-) background. We found that oncogenic Kras-induced TSP-1 upregulation in a p53-dependent manner. TSP-1 functioned in a positive feedback loop to stabilize p53 by interacting directly with activated ERK. TSP-1 tethering of ERK in the cytoplasm promoted a level of MAPK signaling that was sufficient to sustain p53 expression and a senescence response. Our data identify TSP-1 as a p53 target that contributes to maintaining Ras-induced senescence in the lung.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据